CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

May 31, 2016

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG

Januvia Tab. 100mg

Januvia Tab. 100mg\*1T/day for 5days, QD, PO

DRUG

Januvia Tab. 100mg + Duvie Tab. 0.5mg

Januvia Tab.100mg + Duvie Tab. 0.5mg\*1T/day for 5 dyas, QD, PO

Trial Locations (1)

Chonbuk National University Hospital, Jeonju